Katie Kalvaitis

CHICAGO — The rate of deaths from CVD increased in rural areas and decreased in urban areas of the U.S. from 2010 to 2022, and the difference was

CHICAGO — An AI-enabled tool utilizing machine learning, high-speed images and video accurately detected hypertension and type 2 diabetes among

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy

CHICAGO — A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin reduced transthyretin levels in patients with cardiac amyloidosis, researchers reported at the American Heart Association Scientific Sessions.Researchers administered the CRISPR-Cas9-based therapy, nexiguran ziclumeran (nex-z, Intellia/Regeneron) to 36 patients (median age, 78 years; 97% men; 22% Black) with

CHICAGO — Rising outside temperature is associated with increased likelihood for experiencing an episode of atrial fibrillation as detected by implanted cardiac devices, according to new research.

CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared

CHICAGO — In the BRAIN-AF trial, daily rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack, compared

CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage

CHICAGO — Adults who received bystander CPR within the first few minutes of an out-of-hospital cardiac arrest were much more likely to survive and have better brain function than those who did not, researchers reported.

Key takeaways: A speaker highlighted key advances in the treatment of hypertension in 2024.